Point72 Asset Management L.P. Has $11.17 Million Holdings in CME Group Inc (CME)

Share on StockTwits

Point72 Asset Management L.P. cut its holdings in CME Group Inc (NASDAQ:CME) by 77.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,132 shares of the financial services provider’s stock after selling 231,626 shares during the period. Point72 Asset Management L.P.’s holdings in CME Group were worth $11,168,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Meeder Asset Management Inc. increased its position in shares of CME Group by 84.8% during the second quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock worth $129,000 after purchasing an additional 362 shares in the last quarter. Kaizen Advisory LLC increased its position in shares of CME Group by 151.9% during the second quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock worth $134,000 after purchasing an additional 492 shares in the last quarter. Signaturefd LLC acquired a new stake in shares of CME Group during the first quarter worth about $138,000. Old Mutual Global Investors UK Ltd. acquired a new stake in shares of CME Group during the first quarter worth about $138,000. Finally, McKinley Carter Wealth Services Inc. acquired a new stake in shares of CME Group during the first quarter worth about $142,000. Institutional investors own 84.04% of the company’s stock.

NASDAQ CME opened at $173.15 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.08 and a current ratio of 1.08. CME Group Inc has a 52-week low of $130.37 and a 52-week high of $177.35. The stock has a market cap of $58.28 billion, a P/E ratio of 36.30, a P/E/G ratio of 3.23 and a beta of 0.64.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the company posted $1.22 earnings per share. The business’s revenue was up 14.6% on a year-over-year basis. analysts predict that CME Group Inc will post 6.65 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 25th. Investors of record on Monday, September 10th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date is Friday, September 7th. CME Group’s dividend payout ratio is currently 58.70%.

In related news, Director Martin J. Gepsman sold 300 shares of the firm’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $172.30, for a total transaction of $51,690.00. Following the transaction, the director now owns 42,912 shares of the company’s stock, valued at $7,393,737.60. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Ronald A. Pankau sold 260 shares of the firm’s stock in a transaction dated Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the transaction, the director now directly owns 3,900 shares in the company, valued at approximately $636,363. The disclosure for this sale can be found here. In the last three months, insiders have sold 29,188 shares of company stock worth $4,934,232. Corporate insiders own 0.57% of the company’s stock.

CME has been the topic of a number of research analyst reports. Jefferies Financial Group reiterated a “buy” rating and set a $190.00 target price on shares of CME Group in a research report on Wednesday, September 5th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 28th. Zacks Investment Research cut CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 5th. Wells Fargo & Co lifted their target price on CME Group from $170.00 to $175.00 and gave the stock a “market perform” rating in a research report on Monday, July 9th. Finally, Compass Point initiated coverage on CME Group in a research report on Monday, July 9th. They set a “neutral” rating and a $170.00 target price on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $174.40.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Further Reading: How to Invest in Growth Stocks

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply